S Malcolm

Once-Daily Atomoxetine Treatment for Children With Attention-Deficit/Hyperactivity Disorder, Including an Assessment of Evening and Morning Behavior: A Double-Blind, Placebo-Controlled Trial

Douglas K. Kelsey, Calvin R. Sumner, Charles D. Casat et al. · PEDIATRICS · 2004 · 467 citations

Medicine, Pharmacotherapy, Psychiatry +16

Duloxetine, Pregabalin, and Duloxetine Plus Gabapentin for Diabetic Peripheral Neuropathic Pain Management in Patients With Inadequate Pain Response to Gabapentin: An Open-Label, Randomized, Noninferiority Comparison

Robert J. Tanenberg, Gordon Irving, Richard C. Risser et al. · Mayo Clinic Proceedings · 2011 · 125 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

David Ishola, Daniela Manno, Muhammed O. Afolabi et al. · The Lancet Infectious Diseases · 2021 · 95 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

Muhammed O. Afolabi, David Ishola, Daniela Manno et al. · The Lancet Infectious Diseases · 2021 · 93 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Strategies for Switching From Conventional Antipsychotic Drugs or Risperidone to Olanzapine

Bruce J. Kinon, Bruce R. Basson, J. A. Gilmore et al. · The Journal of Clinical Psychiatry · 2000 · 70 citations

Pharmacy, Pharmacotherapy, Psychiatry +16